Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Outcomes of ear endoscopic surgery for petrous bone cholesteatoma].

Zhonghua yi xue za zhi·2025
Same author

Molecular characterisation and expression profile of the <i>PRLR</i> gene during goose ovarian follicle development.

British poultry science·2023
Same author

A 2-year locomotive exploration and scientific investigation of the lunar farside by the Yutu-2 rover.

Science robotics·2022
Same author

Crisaborole: an emerging therapy for prurigo pigmentosa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Golgi phosphoprotein-3 (GOLPH3) promote metastasis of nasopharyngeal carcinoma through regulating E-cadherin.

European review for medical and pharmacological sciences·2020
Same author

Morroniside suppresses hydrogen peroxide-stimulated autophagy and apoptosis in rat ovarian granulosa cells through the PI3K/AKT/mTOR pathway.

Human & experimental toxicology·2020

Related Experiment Video

Updated: Jun 3, 2026

Fabrication and Operation of an Oxygen Insert for Adherent Cellular Cultures
11:56

Fabrication and Operation of an Oxygen Insert for Adherent Cellular Cultures

Published on: January 6, 2010

First implantable device for hypoxia-mediated angiogenic induction.

E Hadjipanayi1, U Cheema, V Mudera

  • 1UCL, Tissue Repair and Engineering Centre, Institute of Orthopaedics, Stanmore Campus, London, HA7 4LP, UK.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|April 5, 2011
PubMed
Summary

Engineered cell-hypoxia in collagen materials effectively delivers angiogenic factors, promoting rapid blood vessel formation for improved tissue perfusion and graft survival.

More Related Videos

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Fabrication and Operation of an Oxygen Insert for Adherent Cellular Cultures
11:56

Fabrication and Operation of an Oxygen Insert for Adherent Cellular Cultures

Published on: January 6, 2010

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Tissue Engineering

Background:

  • Delayed or inadequate vascularization is a primary cause of tissue infarction and poor graft survival.
  • Current single growth factor delivery methods for vascularization are often ineffective or difficult to control.
  • Stimulating physiological angiogenic factor cascades offers a promising alternative approach.

Purpose of the Study:

  • To develop and evaluate a novel, practical, and effective implantable device for on-demand delivery of engineered angiogenic signaling.
  • To investigate the use of localized cell-generated hypoxia within a collagen material to stimulate angiogenic factor production.
  • To assess the in vitro and in vivo efficacy of this angiogenic therapy in promoting vascularization.

Main Methods:

  • Human dermal fibroblast-seeded collagen depots were pre-conditioned under cell-generated hypoxia to induce angiogenic factor production (HIF1α, VEGF165).
  • The correlation between pre-conditioning duration and retained VEGF165 protein levels was analyzed.
  • The angiogenic response was evaluated in vitro using endothelial cell-seeded constructs and in vivo by implanting acellular 3D constructs with angiogenic depots.

Main Results:

  • Pre-conditioning duration directly correlated with the level of VEGF165 protein produced and retained within the depots.
  • Angiogenic factors released from pre-conditioned depots rapidly induced vascularization in vitro.
  • Implanted constructs with angiogenic depots showed significant vessel infiltration and perfusion by 1 week in vivo, unlike non-angiogenic controls.

Conclusions:

  • Engineered local cell-hypoxia within collagen materials is an effective strategy for stimulating angiogenic factor cascades.
  • This novel implantable device provides on-demand delivery of angiogenic signals, promoting rapid and robust vascularization.
  • The stability, tuneability, and cost-effectiveness of this approach make it a promising therapy for improving local tissue perfusion and graft survival.